Novel insights into atopic dermatitis
Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown
notable progress. An increasing number of aspects of the immune system are being …
notable progress. An increasing number of aspects of the immune system are being …
Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review
Importance Observational (nonexperimental) studies that aim to emulate a randomized trial
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
Expert consensus on the systemic treatment of atopic dermatitis in special populations
DN Adam, MJ Gooderham, JR Beecker… - Journal of the …, 2023 - Wiley Online Library
With the increasing number of options for the treatment of moderate‐to‐severe atopic
dermatitis, clinicians need guidance on a practical approach to selecting a systemic agent …
dermatitis, clinicians need guidance on a practical approach to selecting a systemic agent …
Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials
A Wollenberg, LA Beck… - British Journal of …, 2022 - academic.oup.com
Background Tralokinumab, a fully human IgG4 monoclonal antibody that specifically binds
with high affinity to interleukin‐13, effectively reduces moderate‐to‐severe atopic dermatitis …
with high affinity to interleukin‐13, effectively reduces moderate‐to‐severe atopic dermatitis …
Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and …
EL Simpson, JF Merola, JI Silverberg… - British Journal of …, 2022 - academic.oup.com
Background Tralokinumab is a fully human monoclonal antibody that neutralizes the activity
of interleukin‐13, a key pathogenic driver of atopic dermatitis (AD). Clinical trials including …
of interleukin‐13, a key pathogenic driver of atopic dermatitis (AD). Clinical trials including …
Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review
N Neagu, C Dianzani, G Avallone… - Journal of the …, 2022 - Wiley Online Library
Atopic dermatitis (AD) is a chronic, inflammatory skin disorder that most frequently occurs in
children, but it can also affect adults. Even though most AD cases can be managed with …
children, but it can also affect adults. Even though most AD cases can be managed with …
Impact of a decade of research into atopic dermatitis
PD Arkwright, JJ Koplin - The Journal of Allergy and Clinical Immunology …, 2023 - Elsevier
The last decade has seen an unprecedented pace of change, particularly of clinical
research in atopic dermatitis (AD). This review summarizes some key discoveries. Over the …
research in atopic dermatitis (AD). This review summarizes some key discoveries. Over the …
Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination
L Li, LB Robinson, R Patel, AB Landman… - JAMA Network …, 2021 - jamanetwork.com
Importance Allergic history in individuals with confirmed anaphylaxis to a messenger RNA
(mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after …
(mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after …
Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell …
R Achten, J Thijs, M van Der Wal, C van Luijk… - Allergy, 2023 - Wiley Online Library
Background Dupilumab‐associated ocular surface disease (DAOSD) is frequently reported
as side effect in atopic dermatitis (AD) patients. Therefore, the aim of this study was to …
as side effect in atopic dermatitis (AD) patients. Therefore, the aim of this study was to …
[HTML][HTML] Advances in atopic dermatitis
A Plant, MR Ardern-Jones - Clinical Medicine, 2021 - Elsevier
Atopic dermatitis (AD) is a common inflammatory skin disease characterised by itch and is
responsible for significant reduction in quality of life. While AD primarily arises in those …
responsible for significant reduction in quality of life. While AD primarily arises in those …